Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 79 checked references that resolve
resolves10.1016/S0140-6736(12)61728-0Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
resolves10.1002/hipo.22405Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss
resolves10.1186/s12974-015-0339-zPharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer’s disease
resolves10.1186/alzrt26Genetics of Alzheimer disease in the pre- and post-GWAS era
resolves10.1093/nar/gki475WebGestalt: an integrated system for exploring gene sets in various biological contexts
resolves10.1093/nar/gkp427ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
resolves10.1101/gr.1239303Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks
resolves10.1038/nrg2918Network medicine: a network-based approach to human disease
resolves10.1007/s11682-013-9263-yNeuroimaging and genetic risk for Alzheimer’s disease and addiction-related degenerative brain disorders
resolves10.1097/JGP.0b013e3181a2fd07Alcohol Consumption as a Risk Factor for Dementia and Cognitive Decline: Meta-Analysis of Prospective Studies
resolves10.1038/nature14252Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease
resolves10.1016/j.ejphar.2014.06.051Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice
resolves10.1002/mnfr.201400544Role of intestinal microbiota in the generation of polyphenol‐derived phenolic acid mediated attenuation of Alzheimer's disease β‐amyloid oligomerization
resolves10.2174/18715273113126660151A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An Update
resolves10.1007/s12017-012-8201-2Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
resolves10.1074/jbc.M112.424820Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid β (Aβ) Peptide Catabolism and Functionality
resolves10.1038/mp.2010.57Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype
resolves10.1007/s00401-015-1394-3Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer’s disease
resolves10.1016/j.bbrc.2013.01.007Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation
resolves10.1074/jbc.M115.655076ATP-binding Cassette Transporter A7 (ABCA7) Loss of Function Alters Alzheimer Amyloid Processing
resolves10.1186/2051-5960-1-55The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer’s disease
resolves10.3233/JAD-142118An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau
<sub>181</sub>
/Aβ
<sub>1-42</sub>
Ratio in ApoE4-Negative Mild Cognitive Impairment Patients
resolves10.1002/art.24260Unmasking of a protective tumor necrosis factor receptor I–mediated signal in the collagen‐induced arthritis model
resolves10.1093/brain/awv048Memory binding and white matter integrity in familial Alzheimer’s disease
resolves10.1007/s12640-015-9525-0Impairment of Rat Spatial Learning and Memory in a New Model of Cold Water-Induced Chronic Hypothermia: Implication for Alzheimer’s Disease
resolves10.1177/1471301213494530Changes in daily cognition and behavior of Alzheimer’s patients over time: A three-year evaluation using a daily cognition and behavior for Alzheimer’s disease scale
resolves10.1111/j.1365-2990.2012.01281.xAccumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains
resolves10.1186/s12974-015-0369-6Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease
resolves10.1016/j.expneurol.2015.06.008Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease
resolves10.1038/mp.2014.178Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques
resolves10.1016/j.lfs.2015.05.002The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin
resolves10.1016/j.biopsych.2013.12.016Resilience of Precuneus Neurotrophic Signaling Pathways Despite Amyloid Pathology in Prodromal Alzheimer’s Disease
resolves10.1007/s00401-011-0831-1Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease
resolves10.2217/nmt-2015-0012Can Microbiota Research Change Our Understanding of Neurodegenerative diseases?
resolves10.1016/j.pharmthera.2015.11.012Gut microbiome in health and disease: Linking the microbiome–gut–brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases
resolves10.1016/j.bbadis.2014.05.025Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease
resolves10.1016/j.cell.2013.03.030Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
resolves10.1038/mp.2013.77Rare autosomal copy number variations in early-onset familial Alzheimer’s disease
resolves10.1074/jbc.M113.515056F-box Only Protein 2 (Fbxo2) Regulates Amyloid Precursor Protein Levels and Processing
resolves10.1016/j.cell.2006.03.032A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration
resolves10.1096/fj.10-163535VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin
resolves10.1007/s12035-014-8799-1Protective Effects of Humanin and Calmodulin-Like Skin Protein in Alzheimer’s Disease and Broad Range of Abnormalities
resolves10.1007/s12264-014-1479-3Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats
resolves10.1038/ng1934Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
resolves10.1016/j.jalz.2010.03.013Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans
resolves10.1002/humu.22117Locus‐specific mutation databases for neurodegenerative brain diseases
resolves10.1186/2041-1480-4-20The Gene Ontology (GO) Cellular Component Ontology: integration with SAO (Subcellular Anatomy Ontology) and other recent developments
The 3 references without a DOI — listed, not checked
no DOI — not checkedErdos P, Rényi A. On the evolution of random graphs. Publ Math Inst Hungar Acad Sci. 1960;5:17–61.
no DOI — not checkedKong W, Zhang J, Mou X, Yang Y. Integrating gene expression and protein interaction data for signaling pathway prediction of Alzheimer’s disease. Comput Math Methods Med. 2014;2014:340758.
no DOI — not checkedCatanzaro R, Anzalone M, Calabrese F, Milazzo M, Capuana M, Italia A, Occhipinti S, Marotta F. The gut microbiota and its correlations with the central nervous system disorders. Panminerva Med. 2015;57(3):127–43.
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.